The two recovery peptides everyone asks about. Different mechanisms, often stacked together.
Bottom line: These two are not really competitors — they work through completely different pathways and most serious recovery protocols stack them together (the 'Wolverine stack'). If you must pick one, BPC-157 for tendons and gut, TB-500 for larger systemic injuries. If you can run both, the combo covers more ground than either alone.
| BPC-157 | TB-500 | |
|---|---|---|
| Category | Gastric pentadecapeptide (healing) | Thymosin Beta-4 fragment (healing) |
| Mechanism | Drives angiogenesis, modulates nitric oxide, upregulates growth factor receptors on tendon fibroblasts | Binds G-actin to promote cell migration and tissue remodeling at injury sites |
| Reported dose | 250–500 mcg/day subcutaneous | 2–5 mg subcutaneous, 1–2x per week |
| Frequency | Daily injection for 4–8 weeks | 1–2x weekly for 4–8 weeks |
| Weight loss (trials) | Not a weight loss peptide | Not a weight loss peptide |
| Top side effect | Minimal reported — occasional injection site redness, mild nausea with oral form | Headache, lethargy, and head rush reported by some users |
| Evidence tier | Tier 2 — strong animal data, limited human trials (one knee study, n=12) | Tier 2 — strong animal data for wound and cardiac repair, no completed human trials |
| Common vial size | 5 mg vials (most common) | 5 mg or 10 mg vials |
| Approval status | Not FDA-approved. Moved from Category 2 to Category 1 (Feb 2026) — compoundable with Rx | Not FDA-approved. Also moved to Category 1 (Feb 2026) — compoundable with Rx |
BPC-157 is the better solo pick for tendon and ligament injuries, gut issues (leaky gut, IBD, NSAID damage), and localized inflammation. It has a broader use case and can be taken orally for gut-specific targets. Most people start here.
TB-500 shines for systemic healing — post-surgical recovery, chronic muscle injuries, and situations where you need cell migration across a larger area. Its longer half-life means fewer injections per week.
These two are not really competitors — they work through completely different pathways and most serious recovery protocols stack them together (the 'Wolverine stack'). If you must pick one, BPC-157 for tendons and gut, TB-500 for larger systemic injuries. If you can run both, the combo covers more ground than either alone.
← Browse all peptides | All comparisons →
vialprep research · Sources: PubMed, FDA, peer-reviewed trials · How we verify